Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 27 Issue 5 • September–October 2019

Colleagues: Recently Tenured

DANIEL R. LARSON, PH.D., NCI-CCR

Senior Investigator and Head, Systems Biology of Gene Expression Section, Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, National Cancer Institute

Dan Larson

Training: Postdoctoral fellow, Department of Anatomy and Structural Biology, Albert Einstein College of Medicine (The Bronx, New York)

Education: Ohio State University, Columbus, Ohio (B.S. in physics); Cornell University, Ithaca, New York (M.S. and Ph.D. in biophysics)

Outside interests: Hiking; gardening; swimming

Website: https://irp.nih.gov/pi/daniel-larson

Research interests: For more than 20 years, I have been using single-molecule analysis to solve biological problems in living cells. The primary goal of my laboratory is to understand gene expression in eukaryotic cells, starting from the mechanistic behavior of individual macromolecules and proceeding to their regulation in cells and tissue. I apply a biophysical approach to eukaryotic transcriptional regulation. The view that has emerged from these studies is that gene regulation is a dynamic process resulting in stochastic (random) variation within populations. It is now well known that gene-expression heterogeneity arises in large part through the fluctuations in transcriptional activity.

My lab is also developing the tools to explore both the mechanisms of RNA splicing and the consequences of stochastic RNA processing for phenotype selection and disease progression. This work on splicing factor mutations in leukemia revealed a novel pathway of translational regulation and represents a new direction for the lab but one that is a natural evolution of my overarching focus on gene expression in single cells. Ongoing work in the lab now focuses on understanding the dynamic interplay among transcription, splicing, and translation during the formation of blood cells.


JI LUO, PH.D., NCI-CCR

Senior Investigator, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute

Ji Luo

Education: University of Cambridge, Cambridge, United Kingdom (B.A. in natural sciences); Harvard University, Cambridge, Massachusetts (Ph.D. in cellular and developmental biology)

Training: Postdoctoral fellow, Department of Genetics, Harvard Medical School, Brigham and Women’s Hospital (Boston)

Came to NIH: In 2010

Outside interests: Cycling; hiking; photography; painting

Website: https://irp.nih.gov/pi/ji-luo

Research interests: My long-term research goal is to understand the biology of the RAS oncogene and identify new therapeutic strategies for RAS mutant cancers. Most of these cancers are lung, colorectal, and pancreatic adenocarcinomas that harbor mutations in one specific member of the RAS family: KRAS. The KRAS gene encodes a small GTPase protein that plays a key role in mitogenic signaling pathways that control cell growth, cell division, cell differentiation, and cell death. Currently, there are no effective targeted therapies for KRAS mutant cancers.

During my postdoctoral training, I helped discover several vulnerabilities in KRAS mutant cancer cells and develop the concept of “non-oncogene addiction.” Oncogene addiction is the dependency of certain tumor cells on oncogene-activated pathways; non-oncogene addiction is the dependency of cancer cells on non-cancer pathways such as metabolic adaptation, DNA repair, and protein homeostasis for survival. We proposed that non-oncogene addiction presents new therapeutic opportunities.

Today, my lab is particularly interested in understanding how oncogenic stress (cellular damage associated with malignant transformation) gives rise to non-oncogene addiction and synthetic lethality (a combination of alterations in two or more genes that lead to cell death) in KRAS mutant cancer cells, and how we could exploit this phenomenon to discover novel treatment paradigms. Recently, we found that KRAS mutant cells are critically dependent on the autophagy pathway for survival when mitogenic signaling is inhibited. The resulting new target-combination strategy is being evaluated in clinical trials.

In parallel, we have developed CRISPR gene-editing and pharmacological platforms to identify target and drug combinations for the effective elimination of KRAS mutant cells. We are also working closely with the NCI RAS Initiative [https://www.cancer.gov/research/key-initiatives/ras] to translate our discoveries into therapies.


JOSEPH M. ZIEGELBAUER, PH.D., NCI-CCR

Senior Investigator, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute

 JOSEPH M. ZIEGELBAUER

Education: Cornell University, Ithaca, New York (B.S. in biology and biochemistry); University of California at Berkeley, Berkeley, California (Ph.D.)

Training: Postdoctoral fellow, Department of Microbiology, University of California at San Francisco (San Francisco, California)

Came to NIH: In 2008

Outside interests: Biking; swimming with his two children; astrophotography

Website: https://irp.nih.gov/pi/joseph-ziegelbauer

Research interests: Kaposi’s sarcoma-associated herpesvirus (KSHV) causes Kaposi’s sarcoma, the most common form of which develops in people living with HIV. My primary focus is elucidating the functions of microRNAs (miRNAs) expressed by KSHV, a human-cancer virus that expresses multiple viral miRNAs. These viral miRNAs are more abundant than human miRNAs in KSHV-infected patient-derived cell lines. I was one of the first scientists to publish a screen for viral miRNA targets using gene-expression analysis. In addition, my group published the first proteomic screen for viral miRNA targets in primary human cells, found that a human protein could cleave miRNA precursors of KSHV and Epstein-Barr virus (which causes mononucleosis, and published that a form of cholesterol can repress KSHV infection. By developing modified methods to identify dozens of miRNA target genes that are missed using standard approaches, we contributed to new insights into miRNA target discovery. We also identified the first human circular RNA that can inhibit KSHV infection, discovered viral circular RNAs, and found that some viral circular RNAs can regulate cell proliferation.

This page was last updated on Thursday, March 31, 2022

  • Issue Overview
  • Features
    • Building a Better RSV Vaccine
    • Smoldering Spots in the Brains May Signal Severe MS
    • Neuroimaging Connects Genetic Mutations to Behavioral Traits
    • FAES: 60 Years and Counting
    • Extraordinary Neural Circuits
  • Departments
    • From the Deputy Director for Intramural Research
    • New Methods
    • Commentary
    • Colleagues: Recently Tenured
    • News Briefs
    • Research Briefs
    • News You Can Use: Resources
    • The Training Page
    • The SIG Beat
    • Scientific Moment
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search